dimethyl itaconate has been researched along with Mastitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Fu, Y; Guo, J; He, Z; Hu, X; Jiang, P; Li, Y; Yuan, X; Zhang, N; Zhao, C | 1 |
1 other study(ies) available for dimethyl itaconate and Mastitis
Article | Year |
---|---|
Dimethyl itaconate protects against lippolysacchride-induced mastitis in mice by activating MAPKs and Nrf2 and inhibiting NF-κB signaling pathways.
Topics: Animals; Cytokines; Disease Models, Animal; Down-Regulation; Female; Heme Oxygenase-1; Humans; I-kappa B Proteins; Inflammation; Lipopolysaccharides; Mammary Glands, Human; MAP Kinase Signaling System; Mastitis; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase Kinases; NF-E2-Related Factor 2; NF-kappa B; Phosphorylation; Protective Agents; Signal Transduction; Succinates; Toll-Like Receptor 4; Transcription Factor RelA; Up-Regulation | 2019 |